IP Library Granted Patent US 9,480,734
Granted Patent B2
US 9,480,734 · App. 14/420,946 · Granted Nov 1, 2016

Immunogenic composition of killed leptospira bacteria

Inventors: Henricus Leo Bernardus Maria Klaasen (Wijchen, NL); Eric Onno Rijke (Boxmeer, NL)
Assignee: Intervet Inc.
A61K39/0225A61K47/183A61K2039/521
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,480,734
App. No.
14/420,946
Granted
Nov 1, 2016
Kind
B2
Abstract

The present invention pertains to a composition containing an immunogenic cell preparation of killed Leptospira bacteria in an ethylenediaminetetraacetic acid solution. The invention also pertains to a vaccine to protect an animal against an infection with leptospira bacteria, wherein the vaccine comprises this composition. Also, the invention pertains to the use of ethylenediaminetetraacetic acid to stabilize an immunogenic preparation of killed Leptospira bacteria in a liquid carrier, by dissolving the ethylenediaminetetraacetic acid in the carrier.

Claims (8)

1. A composition comprising an immunogenic cell preparation of killed whole cell Leptospira bacteria and 5 to 50 mmols of ethylenediaminetetraacetic acid (EDTA) per liter solution; wherein the killed whole cell Leptospira bacteria are Leptospira interrogans serogroup Australis serovar Bratislava.

2. The composition of claim 1 , wherein the solution comprises 20 mmols of ethylenediaminetetraacetic acid per liter titre.

3. The composition of claim 1 , wherein the solution contains dibasic sodium phosphate.

4. The composition of claim 2 , wherein the solution contains dibasic sodium phosphate.

5. A vaccine to protect an animal against an infection with Leptospira bacteria, wherein the vaccine comprises the composition of claim 1 .

6. A vaccine to protect an animal against an infection with Leptospira bacteria, wherein the vaccine comprises the composition of claim 2 .

7. A vaccine to protect an animal against an infection with Leptospira bacteria, wherein the vaccine comprises the composition of claim 3 .

8. A vaccine to protect an animal against an infection with Leptospira bacteria, wherein the vaccine comprises the composition of claim 4 .

Assignments (2)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2016
From: KLAASEN, HENRICUS LEO BERNARDUS MARIA; RIJKE, ERIC ONNO
To: INTERVET, INC.
Reel/Frame 038523/0798 →
Priority Claims (1)
EP 12180793 · Aug 17, 2012 · regional
Continuity (1)
Related Publication 20150231223A1 · Aug 20, 2015